Citations

Showing 10 of 108104 citations.

Musculoskeletal Injury Risk After Sport-Related Concussion: A Systematic Review and Meta-analysis
McPherson, April L. , Nagai, Takashi , Hewett, Timothy E. , Nagai, Takashi , Webster, Kate E.

Mayo Clinic

The American Journal of Sports Medicine | August 3, 2018 | Volume: 47 | Issue: 7 | Pages: 1754-1762

10.1177/0363546518785901 | PMID 30074832 Get It

Background: Clinical management of sport-related concussion typically involves a symptom checklist, clinical examination of mental status, and neurocognitive testing. However, recent studies have identified unresolved, impaired sensorimotor function after athletes return to sport. A review and meta-analysis of all current literature regarding risk of subsequent musculoskeletal (MSK) injury after concussion has yet to be published in the medical literature. Purpose/Hypothesis: To determine the odds that athletes will sustain MSK injury after concussion. It was hypothesized a priori that concussion would increase the risk for MSK injury. Study Design: Systematic review and meta-analysis. Methods: PubMed and Google Scholar were searched from January 2000 to November 2017. Reference lists of the included studies were manually searched. Two reviewers independently searched the literature for studies published in English that reported MSK injury after athletes returned to play following a concussion. Two independent reviewers completed data extraction using PRISMA guidelines and assessed study quality using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies from the National Institutes of Health. Random effects meta-analyses were used to calculate odds ratio (OR) and incidence rate ratio (IRR) of MSK injury after concussion. The primary study outcome of interest was the number of athletes who sustained MSK injury after concussion. Results: Eight studies met inclusion criteria for meta-analysis. Meta-analysis results indicated that athletes who had a concussion had 2 times greater odds of sustaining a MSK injury than athletes without concussion (OR, 2.11; 95% CI, 1.46-3.06). In addition, athletes with concussion demonstrated a higher incidence of MSK injury after return to sport compared with nonconcussed athletes (IRR, 1.67; 95% CI, 1.42-1.96). Further analysis showed that both male and female athletes with concussion were at an increased risk of MSK injury compared with their respective same-sex, nonconcussed controls (OR > 1.56, P < .01). Conclusion: Based on the evidence of higher risk of MSK injuries after concussion, standard clinical assessments for athletes with concussion should include not only physical symptoms and cognitive function before return to sport but also neuromuscular risk factors associated with increased risk for MSK injuries.
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial
Peyrin‐Biroulet, Laurent , Zou, Guangyong , Casteele, Niels Vande , Pai, Reetesh K. , Marchal-Bressenot, Aude, Stitt, Larry, Shackelton, Lisa M. , Khanna, Reena , D’Haens, Geert , Sandborn, William J. , Olson, Allan, Feagan, Brian G. , Pai, Rish K. , Vande Casteele, N , Peyrin-Biroulet, Laurent , Jairath, Vipul , Mosli, Mahmoud Hisham , Valasek, Mark A. , Zou, Guangyong

Mayo Clinic

Gut | August 3, 2018 | Volume: 68 | Issue: 7 | Pages: 1162-1168

10.1136/gutjnl-2018-316702 | PMID 30076171 Get It

Objective We evaluated the reliability and responsiveness of available but incompletely validated UC histological disease activity indices using standardised rules for centralised assessment. Design Disease activity was assessed in biopsies collected in a phase II placebo-controlled ozanimod trial by four blinded pathologists using the Geboes (GS) and modified Riley (MRS) scores, the Robarts Histopathology (RHI) and Nancy Histological (NHI) indices and a Visual Analogue Scale. Reliability was assessed with intraclass correlation coefficients (ICCs). Index responsiveness was evaluated by assessing longitudinal validity (Pearson correlations of changes in index scores and other disease measures), and effect size estimates (standardised effect size (SES)) using two criteria for change (treatment assignment and >2 point decrease in total Mayo Clinic score). Area under the receiver operating characteristic (AUROC) curve estimates evaluated the probability of the indices to discriminate between treatment and placebo. Results Inter-rater reliability of the histological indices was substantial to almost perfect (ICC>0.61), and responsiveness was moderate to large (SES estimates>0.5); 0.81 (0.52, 1.10), 0.87 (0.58, 1.17), 0.57 (0.30, 0.84) and 0.81 (0.52, 1.09) when treatment assignment was the criterion for change and 1.05 (0.80, 1.31), 1.13 (0.87, 1.39), 0.88 (0.64, 1.12) and 1.06 (0.80, 1.31) for the change in Mayo score criterion for the GS, MRS, RHI and NHI, respectively. The indices had similar drisciminative ability based on AUROC estimates (range 0.608–0.649). Conclusion All four existing histological indices were similarly reliable and responsive based on this dataset.
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population
Piras, Doloretta, Masala, Marco , Urru, Silvana Anna Maria , Curreli, Nicolò, Balaci, Lenuta, Ferreli, Liana, Loi, Francesco , Atzeni, Alice, Racugno, Walter, Steri, Maristella , Fiorillo, Edoardo , Pilia, Maria Grazia, Schlessinger, David , Cucca, Francesco , Pani, Antonello , Delitala, Alessandro , Cabiddu, Gianfranca , Ventura, Laura , Żołędziewska, Magdalena , Rule, Andrew D.

Mayo Clinic

Nephrology Dialysis Transplantation | August 3, 2018 | Volume: 35 | Issue: 4 | Pages: 640-647

10.1093/ndt/gfy270 | PMID 30169833 Get It

AbstractBackgroundThe relationship of kidney size to ageing, kidney function and kidney disease risk factors is not fully understood.MethodsUltrasound length and parenchymal kidney volume were determined from a population-based sample of 3972 Sardinians (age range 18–100 years). We then identified the subset of 2256 ‘healthy’ subjects to define age- and sex-specific reference ranges (2.5–97.5 percentile) of kidney volume. Logistic regression (accounting for family clustering) was used to identify the clinical characteristics associated with abnormally large kidneys or abnormally small kidneys.ResultsIn the healthy subset, kidney volume and length increased up to the fourth to fifth decade of life followed by a progressive decrease in men, whereas there was a gradual kidney volume decrease throughout the lifespan of women. In the whole sample, independent predictors of lower kidney volume (&lt;2.5 percentile for age and sex) were male sex, low body mass index, short height, low waist:hip ratio and high serum creatinine (SCr); the independent predictors of larger kidney volume (&gt;97.5 percentile for age and sex) were younger age, female sex, diabetes, obesity, high height, high waist:hip ratio and lower SCr. Estimated heritability for kidney volume was 15%, and for length 27%; kidney volume correlated strongly with birthweight.ConclusionsOverall, in a general healthy population, kidney measures declined with age differently in men and women. The determinants of kidney parenchymal volume include genetic factors and modifiable clinical factors.
Case for a role of the microbiome in gynecologic cancers: Clinician's perspective
Mert, İsmail , Walther-António, Marina , Mariani, Andrea , Walther-Antonio, Marina

Mayo Clinic

Journal of Obstetrics and Gynaecology Research | August 3, 2018 | Volume: 44 | Issue: 9 | Pages: 1693-1704

10.1111/jog.13701 | PMID 30069974 Get It

Abstract In this review, we aimed to provide insight into the microbiome and its association with endometrial and ovarian cancer and their risk factors. We reviewed the literature focusing on the relationship between the microbiome and cancer, as well as the relationship between gynecologic diseases and cancers. The human body contains different kinds of microorganisms in various body parts, which is termed the microbiome . The number of microorganisms that live in and on the human body is greater than that of the human germ and somatic cells by 10‐fold. The relationship between a human and their microbiome is complex; it is also one of the most important components of homeostasis. Impairment of microbiome–host homeostasis has been associated with obesity, several cancers, preterm labor, inflammatory and allergic conditions and neurodevelopmental disorders. Direct and strong causal relationships have been established for several cancers and microorganisms, such as gastric lymphoma and Helicobacter pylori infection. Interestingly, eradication of the infectious agents has also been shown to be therapeutic. The association between cancer and the microbiome, however, is more complicated than a 1 bacteria–1 cancer model, and a shift in a healthy microbiome can result in various cancers via inflammation, change in microenvironment or DNA‐damaging toxins. The human microbiome is an integral part of homeostasis. Understanding the mechanisms that cause dysbiosis will enable us to elucidate the pathways that result in malignancy and investigate new treatment modalities.
HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma
Lamberti, Dante , Cristinziano, Giulia , Porru, Manuela , Leonetti, Carlo , Egan, Jan B. , Shi, Chang‐Xin, Buglioni, Simonetta , Castellani, Loriana , Anastasi, Sergio, Segatto, Oreste , Amoreo, Carla Azzurra , Borad, Mitesh J. , Alemà, Stefano

Mayo Clinic

Hepatology | August 3, 2018 | Volume: 69 | Issue: 1 | Pages: 131-142

10.1002/hep.30127 | PMID 30067876 Get It

About 15% of intrahepatic cholangiocarcinomas (ICCs) express constitutively active fibroblast growth factor receptor 2 (FGFR2) fusion proteins (FFs) generated by chromosomal translocations. FFs have been nominated as oncogenic drivers because administration of FGFR tyrosine kinase inhibitors (F‐TKIs) can elicit meaningful objective clinical responses in patients carrying FF‐positive ICC. Thus, optimization of FF targeting is a pressing clinical need. Herein, we report that three different FFs, previously isolated from ICC samples, are heat shock protein 90 (HSP90) clients and undergo rapid degradation upon HSP90 pharmacological blockade by the clinically advanced HSP90 inhibitor ganetespib. Combining catalytic suppression by the F‐TKI BGJ398 with HSP90 blockade by ganetespib suppressed FGFR2‐TACC3 (transforming acidic coiled‐coil containing protein 3) signaling in cultured cells more effectively than either BGJ398 or ganetespib in isolation. The BGJ398 + ganetespib combo was also superior to single agents when tested in mice carrying subcutaneous tumors generated by transplantation of FGFR2‐TACC3 NIH3T3 transformants. Of note, FF mutants known to enforce clinical resistance to BGJ398 in ICC patients retained full sensitivity to ganetespib in cultured cells. Conclusion: Our data provide a proof of principle that upfront treatment with the BGJ398 + ganetespib combo improves therapeutic targeting of FGFR2 fusions in an experimental setting, which may be relevant to precision medicine approaches to FF‐driven ICC.
Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma
Antwi, Samuel O. , Habboush, Yacob , Chase, Lori A. , Lee, David D. , Antwi, Samuel O , Lee, David D , Patel, Tushar

Mayo Clinic

Annals of Hepatology | August 3, 2018 | Volume: 17 | Issue: 5 | Pages: 0-10

10.5604/01.3001.0012.2232 Get It

Introduction and aim: Combined hepatocellular-cholangiocarcinoma (HCC-CCA) is a rare liver malignancy distinct from either hepatocellular carcinoma (HCC) or cholangiocarcinoma. Liver transplantation (LT) is not recommended for HCC-CCA because of suboptimal outcomes. Because non-invasive diagnosis of HCC-CCA is extremely challenging, some HCC-CCAs are presumed as HCC on imaging and listed for LT with the correct diagnosis ultimately made on explant pathology. We compared HCC-CCA with HCC to determine the utility of response to pre-transplant loco-regional therapy (LRT) in predicting outcomes for HCC-CCA after LT as a potential means of identifying appropriate HCC-CCA patients for LT. Materials and methods: Retrospective review of 19 patients with pathologically confirmed HCC-CCA individually matched to 38 HCC patients based on age, sex, and Milan criteria at listing was performed. The modified response evaluation criteria in solid tumors was used to categorize patients as responders or non-responders to pre-transplant LRT based on imaging performed before and after LRT. Overall survival (OS) and recurrence-free survival (RFS) were examined. Results: OS at 3 years post-transplant was 74% for HCC-CCA and 87% for HCC. RFS at 3 years was 74% for HCC-CCA, and 87% for HCC. Among responders to LRT, the 3-year OS was 92% for HCC-CCA and 88% for HCC; among non-responders, 3-year OS was 43% for HCC-CCA and 83% for HCC. Higher 3-year OS was observed among HCC-CCA responders (77%) compared with HCC-CCA non-responders (23%). Conclusions: OS was similarly high among responders to pre-transplant LRT irrespective of tumor type. Radiologic response to LRT could potentially be used to select appropriate HCC-CCA patients for LT if the findings are validated in independent studies.
Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes
Mampre, David , Ehresman, Jeffrey, Pinilla-Monsalve, Gabriel David , Osorio, Maria Alejandra Gamboa, Quiñones‐Hinojosa, Alfredo , Chaichana, Kaisorn L. , Osorio, María Alejandra Gamboa, Olivi, Alessandro

Mayo Clinic

British Journal of Neurosurgery | August 3, 2018 | Volume: 32 | Issue: 5 | Pages: 528-535

10.1080/02688697.2018.1498450 | PMID 30073866 Get It

Sirt6 deficiency impairs corneal epithelial wound healing
Zhu, Shuang , Miller, Jordan D. , Merkley, Kevin H., Tilton, Ronald G. , Liu, Hua , Hu, Xiaobing, Liu, Rong , Miller, Jordan

Mayo Clinic

Aging | August 2, 2018 | Volume: 10 | Issue: 8 | Pages: 1932-1946

10.18632/aging.101513 | PMID 30070973 Get It

Bi-directional Dideoxy Fingerprinting (Bi-ddF): Rapid and Efficient Screening for Mutations in the Big Blue TM Transgenic Mouse Mutation Detection System
Sommer, Steve S., Haavik, Jan , Nishino, Hiroshi, Liu, Qiang

Mayo Clinic

BioTechniques | August 2, 2018 | Volume: 20 | Issue: 6 | Pages: 988-994

10.2144/96206bm11 | PMID 8780870 Get It

Faculty Opinions recommendation of Clonidine effect on pain after cesarean delivery: A randomized controlled trial of different routes of administration.
Sviggum, Hans P.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 2, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732925325.793548819 Get It